The effect of inhaled lidocaine-hydrofluoroalkane 134a in prednisone-dependent eosinophilic bronchitis.
Duong
M
M
Wilson
A M
AM
Jayaram
L
L
Dolovich
M
M
Hargreave
F
F
D000280:Administration, Inhalation; D000328:Adult; D000335:Aerosol Propellants / Q000008:administration & dosage; D000368:Aged; D001991:Bronchitis / Q000628:therapy*; D018592:Cross-Over Studies; D004804:Eosinophils / Q000187:drug effects*; D005260:Female; D006801:Humans; D006845:Hydrocarbons, Fluorinated / Q000008:administration & dosage*; D008012:Lidocaine / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011241:Prednisone / Q000494:pharmacology*; D016896:Treatment Outcome; D005466:Fluorocarbons
D000335:Aerosol Propellants; D006845:Hydrocarbons, Fluorinated; D008012:Lidocaine; D010919:Placebos; D011241:Prednisone; C094049:apaflurane; D005466:Fluorocarbons